Quantification of muscle pathology in infantile Pompe disease

被引:19
|
作者
Schaenzer, Anne [1 ]
Kaiser, Ann-Kathrin [1 ]
Muehlfeld, Christian [2 ]
Kulessa, Martin [1 ]
Paulus, Werner [3 ]
von Pein, Harald [4 ]
Rohrbach, Marianne [5 ]
Viergutz, Lara [1 ]
Mengel, Eugen [6 ]
Marquardt, Thorsten [7 ]
Neubauer, Bernd [8 ]
Acker, Till [1 ]
Hahn, Andreas [8 ]
机构
[1] Justus Liebig Univ, Inst Neuropathol, Giessen, Germany
[2] Hannover Med Sch, Inst Funct & Appl Anat, Hannover, Germany
[3] Univ Med Ctr, Inst Neuropathol, Munster, Germany
[4] Univ Med Ctr JGU Univ, Dept Neuropathol, Mainz, Germany
[5] Univ Childrens Hosp, Childrens Res Ctr, Div Metab, Zurich, Switzerland
[6] Univ Med Ctr JGU Univ, Villa Metab, Mainz, Germany
[7] Westfal Wilhelms Univ, Dept Pediat, Munster, Germany
[8] Justus Liebig Univ, Dept Child Neurol, Giessen, Germany
关键词
Pompe disease; Glycogen storage disease type II; Enzyme replacement therapy; Lysosomal storage disease; Acid maltase deficiency; Autophagy; ENZYME REPLACEMENT THERAPY; ACID ALPHA-GLUCOSIDASE; CLASSIC INFANTILE; CRIM STATUS; AUTOPHAGY;
D O I
10.1016/j.nmd.2016.10.010
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The effects of enzyme replacement therapy (ERT) in infantile Pompe disease are variable, necessitating the identification of biomarkers to assess the severity of disease and response to ERT. The aims of this study were to investigate whether quantification of muscle pathology in infantile Pompe disease prior to and during ERT is feasible at the light microscope, and to develop a score that summarizes the degree of muscle pathology in a comprehensive manner from PAS-stained resin sections alone. We, therefore, determined glycogen load, extent of muscle fibre disruption, and amount of autophagic vacuoles in resin-embedded muscle biopsy specimens from 11 infantile Pompe patients and 2 with early childhood phenotype by quantitative methods, correlated the findings with ultrastructural analyses, compared PAS-stained resin sections with conventional PAS-stained cryosections, and related the quantified degree of muscle damage from infantile patients to the effects of ERT. Comparison of electron and light microscopic findings demonstrated that important alterations of skeletal muscle morphology can also be depicted by examining PAS stained resin sections. Infantile patients with good response to ERT had lower muscle pathology score values prior to and during ERT than those with moderate and poor response, but the number of tissue samples available for evaluation was limited. These findings suggest that quantification of muscle pathology by analysing PAS stained resin sections is in principle feasible and useful to monitor disease progression and therapy response. These results have to be validated by investigating a larger group of patients. (C) 2016 Elsevier B.V. All rights reserved.
引用
收藏
页码:141 / 152
页数:12
相关论文
共 50 条
  • [21] Neuroimaging findings in infantile Pompe patients treated with enzyme replacement therapy
    Mclntosh, Paul T.
    Hobson-Webb, Lisa D.
    Kazi, Zoheb B.
    Prater, Sean N.
    Banugaria, Suhrad G.
    Austin, Stephanie
    Wang, Raymond
    Enterline, David S.
    Frush, Donald P.
    Kishnani, Priya S.
    MOLECULAR GENETICS AND METABOLISM, 2018, 123 (02) : 85 - 91
  • [22] Autophagy and mistargeting of therapeutic enzyme in skeletal muscle in Pompe disease
    Fukuda, Tokiko
    Ahearn, Meghan
    Roberts, Ashley
    Mattaliano, Robert J.
    Zaal, Kristien
    Ralston, Evelyn
    Plotz, Paul H.
    Raben, Nina
    MOLECULAR THERAPY, 2006, 14 (06) : 831 - 839
  • [23] Resolution of severe cardiomyopathy in infantile Pompe disease
    Parent, John J.
    Schamberger, Marcus
    CARDIOLOGY IN THE YOUNG, 2015, 25 (01) : 146 - 148
  • [24] Failure of Autophagy in Pompe Disease
    Do, Hung
    Meena, Naresh K.
    Raben, Nina
    BIOMOLECULES, 2024, 14 (05)
  • [25] AAV-mediated transcription factor EB (TFEB) gene delivery ameliorates muscle pathology and function in the murine model of Pompe Disease
    Gatto, Francesca
    Rossi, Barbara
    Tarallo, Antonietta
    Polishchuk, Elena
    Polishchuk, Roman
    Carrella, Alessandra
    Nusco, Edoardo
    Alvino, Filomena Grazia
    Iacobellis, Francesca
    De Leonibus, Elvira
    Auricchio, Alberto
    Diez-Roux, Graciana
    Ballabio, Andrea
    Parenti, Giancarlo
    SCIENTIFIC REPORTS, 2017, 7
  • [26] Immune responses to alglucosidase in infantile Pompe disease: recommendations from an Italian pediatric expert panel
    Gragnaniello, Vincenza
    Deodato, Federica
    Gasperini, Serena
    Donati, Maria Alice
    Canessa, Clementina
    Fecarotta, Simona
    Pascarella, Antonia
    Spadaro, Giuseppe
    Concolino, Daniela
    Burlina, Alberto
    Parenti, Giancarlo
    Strisciuglio, Pietro
    Fiumara, Agata
    Della Casa, Roberto
    ITALIAN JOURNAL OF PEDIATRICS, 2022, 48 (01)
  • [27] The earliest enzyme replacement for infantile-onset Pompe disease in Japan
    Tocan, Vlad
    Mushimoto, Yuichi
    Kojima-Ishii, Kanako
    Matsuda, Akane
    Toda, Naoko
    Toyomura, Daisuke
    Hirata, Yuichiro
    Sanefuji, Masafumi
    Sawada, Takaaki
    Sakai, Yasunari
    Nakamura, Kimitoshi
    Ohga, Shouichi
    PEDIATRICS INTERNATIONAL, 2022, 64 (01)
  • [29] Arrhythmias in patients receiving enzyme replacement therapy for infantile Pompe disease
    McDowell, Roddy
    Li, Jennifer S.
    Benjamin, Daniel Kelly, Jr.
    Morgan, Claire
    Becker, Alison
    Kishnani, Priya S.
    Kanter, Ronald J.
    GENETICS IN MEDICINE, 2008, 10 (10) : 758 - 762
  • [30] Clinical laboratory experience of blood CRIM testing in infantile Pompe disease
    Bali, Deeksha S.
    Goldstein, Jennifer L.
    Rehder, Catherine
    Kazi, Zoheb B.
    Berrier, Kathryn L.
    Dai, Jian
    Kishnani, Priya S.
    MOLECULAR GENETICS AND METABOLISM REPORTS, 2015, 5 : 76 - 79